Table 1.
Reactivity to regional specific proteins of HCV and clinical characteristics in patients with chronic HCV infection
| C22-3
|
C33C
|
C100-3
|
5-1-1
|
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (+) | vs | (−) | (+) | vs | (−) | (+) | vs | (−) | (+) | vs | (−) | |
| No.(%) | 41(91.1) | 4(8.9) | 41(91.1) | 4(8.9) | 29(64.4) | 16(35.6) | 24(53.3) | 21(46.7) | ||||
| Sex(M,F) | 28, 13 | 20, 2 | 18, 13 | 2, 2 | 21, 8 | 9, 7 | 17, 7 | 13, 8 | ||||
| Age (mean±SD) | 50.6±13.8, | 49.5±11.9 | 51.7±13.3, | 39.7±11.1 | 47.5±12.9, | 56.2±13.1 | 46.2±12.7 | 55.6±12.9 | ||||
| CH(%) | 30(90.0) | 3(10.0) | 31(93.9) | 2(6.1) | 26(78.8) | 7(21.2) | 21(63.6) | 12(36.4) | ||||
| HCC(%) | 11(91.7) | 1(8.3) | 10(83.3) | 2(16.7) | 3(25.0) | 9(75.0) | 3(25.0) | 9(75.0) | ||||
CH; chronic hepatitis, HCC; Hepatocellular carcinoma